NURS 615 PHARM EXAM 1 – MARYVILLE
COMPLETE (208) CURRENT TESTING
QUESTIONS AND CORRECT DETAILED
ANSWERS|TOP-RATED A+
NURS 615
Prepare for the NURS 615 Pharm Exam 1 – Maryville with
this concise study resource covering core pharmacology
concepts, medication classifications, and exam-style
questions. It reinforces key topics commonly taught in
courses at Maryville University. Designed to improve
understanding and exam readiness. Suitable for nursing
students studying pharmacology.
How does hypoalbuminemia affect the process of
prescribing? ✓ ✓ ...... ANSWER ....... Low albumin =
more free drug (bc the drug can't bind to albumin aka
protein) = increased adverse effects
What is a Black Box Warning: ✓ ✓ ...... ANSWER ....... is
considered a contraindication to administer that drug.
, Page 2 of 59
What is the drugs half-life? ✓ ✓ ...... ANSWER .......
Half-life specifically means the amount of time it takes for
an administered drug to be halfway cleared from the system.
Peak of action: ✓ ✓ ...... ANSWER ....... the time
between drug administration and maximum concentration
of drug in the blood stream. Best therapeutic effect.
Duration of action: ✓ ✓ ...... ANSWER ....... the time
between onset of action and metabolism of drug below the
minimum needed for an effect. The length of time you have
the drug in your system.
According to the WHO what is the first step in the prescribing
process? ✓ ✓ ...... ANSWER ....... The first step is to
define the patient's problem
The second step is to ✓ ✓ ...... ANSWER ....... specify
the therapeutic objective
The third step is to ✓ ✓ ...... ANSWER ....... choose
which drug or treatment is needed.
, Page 3 of 59
Step 4 of the WHO approach: ✓ ✓ ...... ANSWER .......
Start the treatment
Step 5 of the WHO approach: ✓ ✓ ...... ANSWER .......
Educate the patient
Step 6 of the WHO approach: ✓ ✓ ...... ANSWER .......
Monitor the treatment
Phase 1 of drug development: ✓ ✓ ...... ANSWER .......
The drug is tested on healthy volunteers
Phase 2 of drug development: ✓ ✓ ...... ANSWER .......
trials with people who have the disease for which the drug is
thought to be effective
Phase 3 of drug development: ✓ ✓ ...... ANSWER .......
Large numbers of patients in medical research centers
receive the drug in phase 3. This larger sampling provides
information about infrequent or rare adverse effects. The FFA
, Page 4 of 59
will approve a new drug application if phase 3 studies are
satisfactory.
Phase 4 of drug development: ✓ ✓ ...... ANSWER .......
This phase is voluntary and involves postmarket surveillance
of the drug's therapeutic effects at the completion of phase
3. The pharmaceutical company receives reports from
doctors and other health care professionals about the
therapeutic results and adverse effects of the drug. Some
medications, for example, have been found to be toxic and
have been removed from the market after their initial
release.
Explain first pass metabolism ✓ ✓ ...... ANSWER .......
much of the drug is lost in the absorption process. The liver
metabolizes many drugs, thus reduces the bioavailabilty of
the drug.
What is the fasted route of absorption: ✓ ✓ ...... ANSWER
....... The fastest route of absorption is inhalation, and
not as mistakenly considered the IV administration.